Issued Patents All Time
Showing 51–74 of 74 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 5928938 | Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof | Etienne DePlaen, Thierry Boon-Falleur | 1999-07-27 |
| 5925729 | Tumor rejection antigen precursors, tumor rejection antigens and uses thereof | Thierry Boon, Benoit Van den Eynde, Aline Van Pel, Etienne De Plaen, Christophe Lurquin +2 more | 1999-07-20 |
| 5905145 | Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof | Thierry Boon-Falleur | 1999-05-18 |
| 5877017 | Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof | Pascale Boel, Claude Wildmann, Thierry Boon-Falleur, Pierre Coulie, Jean-Christophe Renauld | 1999-03-02 |
| 5858689 | Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof | Benoit Van den Eynde, Olivier DeBacker, Thierry Boon-Falleur | 1999-01-12 |
| 5851523 | Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre Coulie, Thomas F. Gajewski | 1998-12-22 |
| 5763165 | Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3 | Thierry Boon-Falleur, Patrick Weynants, Bernard Lethe, Francis Brasseur, Marie Marchand +3 more | 1998-06-09 |
| 5763155 | Method for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3 gene products | Thierry Boon-Falleur, P. Weynants, Bernard Lethe, Francis Brasseur, M. Patrick Marchand +3 more | 1998-06-09 |
| 5744353 | Cytolytic T cell lines which bind to complexes of tumor rejection antigens and HLA-B44 molecules | Jean Herman, Pierre Coulie, Thierry Boon-Falleur, Immanuel F. Luescher | 1998-04-28 |
| 5695994 | Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules | Thierry Boon-Falleur, Etienne De Plaen, Christophe Lurguin, Catia Traversari, Beatrice Gaugler +1 more | 1997-12-09 |
| 5686068 | Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof | Cornelius Melief, M. W. Visseren, Sjoerd Henricus Van Der Burg, Thierry Boon-Falleur | 1997-11-11 |
| 5683886 | Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof | Thierry Boon-Falleur | 1997-11-04 |
| 5629166 | Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-C-clone 10/MAGE-1 derived peptides, and methods for treating said individuals | Thierry Boon-Falleur | 1997-05-13 |
| 5591430 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre Coulie, Thomas F. Gajewski | 1997-01-07 |
| 5585461 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre Coulie | 1996-12-17 |
| 5571711 | Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors | Thierry Boon-Falleur, Pierre Coulie, Jean-Christophe Renauld | 1996-11-05 |
| 5558995 | Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof | Thierry Boon-Falleur | 1996-09-24 |
| 5554506 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Thierry Boon-Falleur, Catia Traversari, Katharina Fleischauer | 1996-09-10 |
| 5554724 | Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof | Cornelis Joseph Maria Melief, M. J. W. Visseren, W. Martin Kast, Thierry Boon-Falleur | 1996-09-10 |
| 5541104 | Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1 | Yao-Tseng Chen, Elisabeth Stockert, Yachi Chen, Pilar Garin-Chesa, Wolfgang J. Rettig +2 more | 1996-07-30 |
| 5512437 | Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3 | Beatrice Gaugler, Thierry Boon-Falleur, Benoit Van den Eynde, Etienne DePlaen, Francis Basseur +1 more | 1996-04-30 |
| 5462871 | Isolated nucleic acid molecules which encode MAGE derived nonapeptides | Thierry Boon-Falleur, Etienne De Plaen, Christophe Lurquin, Catia Traversari, Beatrice Gaugler +1 more | 1995-10-31 |
| 5405940 | Isolated nonapeptides derived from MAGE genes and uses thereof | Thierry Boon, Etienne De Plaen, Christophe Lurquin, Catia Traversari | 1995-04-11 |
| 5342774 | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 | Thierry Boon, Benoit Van den Eynde, Aline Van Pel, Etienne De Plaen, Christophe Lurquin +2 more | 1994-08-30 |